key: cord-0823144-sb7c53jb
authors: Raposo, Letícia Martins; Abreu, Gabriel Ferreira Diaz; Cardoso, Felipe Borges de Medeiros; Alves, André Thiago Jonathas; Rosa, Paulo Tadeu Cardozo Ribeiro; Nobre, Flávio Fonseca
title: Symptom-based clusters of hospitalized patients with Severe Acute Respiratory Illness by SARS-CoV-2 in Brazil
date: 2022-04-28
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2022.04.013
sha: df6a56f7f8d6d2152940da8100fa1b663ef51359
doc_id: 823144
cord_uid: sb7c53jb

BACKGROUND: COVID-19 has shown a broad clinical spectrum, ranging from asymptomatic to mild, moderate, and severe infections. Many symptoms have already been identified as typical of COVID-19, but few studies show how they can be useful in identifying clusters of patients with different severity of illness. This interpretation may help to recognize the different profiles of symptoms of COVID-19 expressed in a population at certain time. The aim of this study was to identify symptom-based clusters of hospitalized patients with severe acute respiratory illness by SARS-CoV-2 in Brazil. The clusters were evaluated based on sociodemographic characteristics, admission to the Intensive Care Unit (ICU), use of respiratory support, and outcome. METHODS: The Multiple Correspondence Analysis (MCA)-based cluster analysis was applied to symptoms presented before admission. Pearson's chi-square test was used to compare the proportions of symptoms between the clusters and to examine differences in the calculated rates for the following variables: sex, age group, race, Brazilian region, use of respiratory support, admission to the ICU and outcome. RESULTS: Three COVID-19 clusters with distinct symptom profiles were identified by MCA-based cluster analysis. Cluster 1 had the mildest severity profile, with the lowest frequencies for most symptoms investigated. Cluster 2 had a severe respiratory profile, with the highest frequencies of patients with dyspnea, respiratory discomfort and O2 saturation < 95%. Cluster 2 was also the most prevalent in all Brazilian regions and had the highest percentages of patients who used invasive respiratory support (27.4%) (p-value <0.001), were admitted to the ICU (42.6%) (p -value <0.001) and died (39.0%) (p-value <0.001). Cluster 3 had a prominent profile of gastrointestinal symptoms. CONCLUSIONS: The study identified three distinct COVID-19 clusters based on the symptoms presented by patients with severe acute respiratory illness by SARS-CoV-2, but without distinction in their prevalence in the Brazilian regions.

The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is responsible for the Coronavirus Disease 2019 (COVID- 19) , which has a broad clinical spectrum, ranging from asymptomatic to mild, moderate, and severe (~ 15%) infections. About 5% of the cases can progress to critical disease with complications such as acute respiratory distress syndrome, thromboembolism, and/or multi-organ failure [1, 2] .

The most common symptoms of COVID-19 are fever, dry cough, and fatigue.

Some patients experience loss of taste or smell, sore throat, headache, muscle or joint J o u r n a l P r e -p r o o f pain, nausea or vomiting, diarrhea, among others. Patients with severe COVID-19 may also present shortness of breath, loss of appetite, and confusion [1, 3] . The most severe cases often require hospitalization in an Intensive Care Unit (ICU) to ensure assisted respiratory support and other medical treatments [4] . Comorbidities such as asthma, diabetes, cardiovascular and pulmonary diseases, and characteristics such as age, sex, and race have also been associated with the severity of the disease [5] [6] [7] [8] [9] .

Many symptoms have already been identified as typical of COVID-19, but few studies show how they can be useful in identifying clusters of patients with different severity of illness. This interpretation may help to recognize different profiles of symptoms of COVID-19 expressed in a population at a certain time.

It is estimated that as of February 22, 2022 , more than 427 million SARS-CoV-2 infections have been confirmed, resulting in 5,913,601 COVID-19-related deaths worldwide. Among active cases, 0.1% (81,196 of 66,686,087) are in severe or critical condition [10] . In Brazil, to date, 28,250,591 cases have been recorded, with 644,695 deaths. The country was in the third position among the countries in the world with the highest number of registered cases and second place concerning the number of deaths [10] .

Brazil has a flu epidemiological surveillance system that has been recording cases of SARS-CoV-2 infections, including patient information such as sociodemographic characteristics, symptoms, comorbidities, hospitalization, evolution, among others. In this study, we sought to assess the symptoms presented in Brazilian patients with severe acute respiratory illness by SARS-CoV-2 and to identify severity profiles according to these epidemiological characteristics.

This study is based on the public database SIVEP-Gripe (Sistema de Informação de Vigilância Epidemiológica da Gripe-Flu Epidemiological Surveillance System) [11] , a system for recording cases of severe acute respiratory illness (SARI) in Brazil, including data from COVID-19, maintained by the Ministry of Health (https://opendatasus.saude.gov.br/dataset/bd-srag-2021). The Brazilian Guide for Epidemiological Surveillance considered a case of SARI when a person with flu-like illness has dyspnea/respiratory discomfort, or persistent pressure, or pain in the chest, or O2 saturation < 95% in room air, or a bluish discoloration (cyanosis) of the lips or face J o u r n a l P r e -p r o o f [12] . The original data used in this study can be accessed at https://zenodo.org/record/5776398#.YbdFcdDMJPY. The data was downloaded on November 10, 2021.

We included in the study patients aged ≥ 18 years, classified as a case of SARI, with a positive RT-PCR test for SARS-CoV-2, who were admitted to the hospital and with the known outcome as hospital discharge (cure) or death by COVID-19. A stratified random sample proportional to Brazilian states, with an approximate size of 10,000, was considered in the analysis. The date of COVID-19 diagnosis spans the time interval from February, 1 to October 31, 2021.

The variables included in the study were sociodemographic characteristics -Brazilian region (North; Northeast; Center-West; Southeast and South), sex (male and female), age group (18 to 59 years old; ≥ 60 years old), and race (white and non-white); signs and symptoms (fever, cough, sore throat, dyspnea, respiratory discomfort, O2 saturation < 95%, diarrhea, vomiting, abdominal pain, fatigue, and loss of smell or taste); hospitalization (ICU admission, use of respiratory support-invasive, noninvasive and non-use); and outcome (cure or death by SARI). Missing values for symptoms were considered as the absence of these characteristics, and missing values for ICU admissions were considered as non-ICU admissions [13] .

A descriptive analysis was performed. Absolute and percentage frequencies were calculated to summarize the main characteristics of the participants in the study.

Multiple correspondence analysis (MCA) was used to explore the joint association between signs and symptoms. MCA enables the identification of associations among variables when considered simultaneously. This analysis allows a geometrical representation of the results by locating each variable category as a point on the Cartesian axes, according to the frequency of the modalities, so that, closer points indicate that the subjects share the corresponding categories, which finally leads to categories being associated. MCA was performed using the R package FactoMineR [14] , and the factoextra package [15] was used to extract the MCA results.

The hierarchical clustering on principal components from MCA was used to identify groups of patients with similar profiles according to the symptoms. The

Euclidean distance with Ward's agglomeration method was used. This step was performed by the HCPC function from the FactoMineR package, which uses the V test to compare the proportion of the categories in a cluster to the proportion of the J o u r n a l P r e -p r o o f categories in the population. The test is based on the hypergeometric distribution [16] .

The algorithm determined the optimum number of clusters.

Pearson's chi-square test was used to compare the proportions of symptoms between the clusters and to examine differences in the rates of sex, age group, race, Brazilian region, use of respiratory support, admission to the ICU and outcome based on the clusters.

All analyzes were performed in R version 4.1.0 software [17] . A p < 0.05 was considered statistically significant.

A total of 10,011 hospitalized Brazilian patients with SARI by SARS-CoV-2 confirmed by RT-PCR were included in the study. Most hospitalized patients were from the Southeast region (54.9%), adults (56.8%), male (56.4%), and white (58.4%). Among the symptoms, the most common were dyspnea (75.6%), O2 saturation < 95% (72.9%), cough (70.6%), respiratory discomfort (59.9%) and fever (55.6%). Over 60% of patients used non-invasive respiratory support, 38.2% were admitted to ICU and 65.2% were cured (Table 1) . of the total variability. Fatigue and respiratory discomfort were the most correlated with dimension 1. O2 saturation < 95% and dyspnea were the most correlated with dimension 2, with respiratory discomfort also well correlated. Cough and fever were more correlated to dimension 3, fatigue, vomiting and loss of smell and taste to dimension 4, and sore throat to dimension 5. analysis were abdominal pain, cough, diarrhea, dyspnea, fatigue, fever, loss of smell or taste, O2 saturation < 95%, respiratory discomfort, sore throat, and vomiting. The letters -N‖ and -Y‖ represent, respectively, the negative (no) and positive (yes) categories.

We observed proximity between abdominal pain, vomiting, diarrhea, and loss of smell or taste in the first quadrant, which are well represented in the factor map for both dimensions. Fever, cough, sore throat and fatigue were located close together in the right quadrant, with the first three categories in the first quadrant and the last one in the fourth quadrant. Respiratory distress, O2 saturation <95%, and dyspnea were located close together in the fourth quadrant ( Figure 1 ). Table 3 shows the sociodemographic and hospitalization characteristics of patients in each cluster. It is possible to observe a statistically significant difference between the frequencies of the three clusters regarding the variables: age group, gender, respiratory support, ICU and outcome. 

This study aimed to identify the profile of symptoms in the Brazilian COVID-19 cases using MCA combined with cluster analysis. We also evaluated how these profiles differed in terms of sociodemographic characteristics, ICU admission, use of respiratory support and outcome.

Three different clusters were identified according to the prevalence of symptoms. Cluster 1 had the lowest severity profile, with the lowest frequencies for most symptoms investigated. Cluster 2 showed a severe respiratory profile, with the highest frequency of patients with dyspnea, respiratory discomfort, and oxygenation.

Cluster 3 presented a profile with a certain severity, which involved a strong profile of gastrointestinal symptoms. Such characteristics were not present in the other two clusters.

Similar to the present study, Han et al. also identified three clusters, labeled as -severe‖, -classical‖ and -atypical‖ [18] . These clusters were based on the symptoms of 1,035 COVID-19 patients from Wuhan, China. Unlike our study, they used laboratory data. Comparing the results, the -severe‖ cluster in the study by Han and colleagues had high frequencies of fever, fatigue, sore throat, dyspnea, diarrhea, abdominal pain, and vomiting. This profile is similar to our Cluster 3, which also presented high frequencies for these symptoms. The profile of Cluster 2 in our study is like the -classical‖ cluster, which presented intermediate frequencies compared to those of the -severe‖ and -atypical‖ clusters. The -atypical‖ cluster presented the lowest levels of all indicators among the three clusters, being similar to our Cluster 1, being also the cluster with the lowest frequencies for most symptoms investigated. However, in the study conducted confusion; severe level three, abdominal and respiratory symptoms [21, 22] . We observed that Cluster 3 identified in the present study is similar to the Severe level three, abdominal and respiratory cluster, with high percentages for symptoms of these two classes.

When the symptoms clusters were evaluated, Cluster 2 was shown to be the most severe. It had the highest percentages of ICU admission, use of invasive respiratory support, and death. It was the one with the highest frequencies of dyspnea, respiratory discomfort, and O2 saturation < 95%. This shows that these symptoms make the patient's profile more critical, setting alerts for monitoring the disease. Clusters 1 and 3 did not show significant differences regarding the proportions of ICU admission and death. Cluster 3 had higher percentages of use of respiratory support when compared to Cluster 1. Thus, we can classify Cluster 3 as moderate severity and Cluster 1 with a mild profile.

When the clusters were evaluated, based on sociodemographic characteristics, no differences were observed between them for race and Brazilian regions. In fact, for all Brazilian regions, cluster 2 was the most prevalent, followed by clusters 1 and 3. Clusters 1 and 2 had higher percentages of males and elderly (>= 60 years).

Our study had some limitations. The use of secondary data does not guarantee that all patients who presented SARI by SARS-CoV-2 in different Brazilian regions were notified by the surveillance system, since not everyone was tested and/or hospitalized. To ease this situation, we only used data from 2021, when access to RT-PCR exams was greater. It is also noteworthy that the cases evaluated were only patients hospitalized with SARI by SARS-CoV-2. Thus, the profiles identified here refer to cases with some degree of severity, not considering asymptomatic or symptomatic cases of people infected with SARS-CoV-2, and who did not require hospitalization. Finally, although the vaccination campaign against COVID-19 started in 2021 in Brazil, in this study we did not assess differences in symptom profiles between vaccinated and unvaccinated hospitalized patients. The incompleteness of vaccination data and the use of vaccines (Pfizer -BioNTech, Oxford -AstraZeneca, CoronaVac, and Janssen) with different schedules and combinations require deeper analysis that will be the topic of further studies. It is also important to highlight that in the database used there was no information about which strain of SARS-CoV-2 the patient was infected with. J o u r n a l P r e -p r o o f

In our study, Brazilian hospitalized patients with SARI by SARS-CoV-2 were divided into three clusters with different symptom profiles using MCA-based cluster analysis.

We identified three symptom-based clusters: milder cases, moderate cases with gastrointestinal symptoms and more severe cases with respiratory symptoms. It was not possible to observe differences in the proportion of clusters between the five Brazilian regions, with the most severe cluster being the most prevalent in all regions.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. 

WHO. Coronavirus disease (COVID-19) 2020

Clinical management of COVID-19: interim guidance

COVID-19 diagnosis and management: a comprehensive review

Immune Response, Inflammation, and the Clinical Spectrum of COVID-19

Risk Factors for Hospitalization and Mortality due to COVID-19 in Espírito Santo State

Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a J o u r n a l P r e -p r o o f Report of 72314 Cases from the Chinese Center for Disease Control and Prevention

Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis

Risk factors for Covid-19 severity and fatality: a structured literature review

Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France

SRAG 2021 -Banco de Dados de Síndrome Respiratória Aguda Grave -incluindo dados da COVID

Guia de vigilância epidemiológica -Emergência de saúde pública de importância nacional pela doença pelo Coronavírus

Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study

FactoMineR: An R package for multivariate analysis

Extract and Visualize the Results of Multivariate Data Analyses

Exploratory multivariate analysis by example using R

Exploring the Clinical Characteristics of COVID-19 Clusters Identified Using Factor Analysis of Mixed Data-Based Cluster Analysis

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study

Investigation of COVID-19-related symptoms based on factor analysis

Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app

Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool